Developing Advanced Therapies for Retinal Disease

Learn more about our therapies
Our Company

Kiora targets critical pathways underlying vision-threatening retinal diseases using innovative small molecules to slow, stop, or restore vision loss. We focus on conditions with limited or no effective therapies.

View Pipeline & Science
NEWS
Loading RSS Feed

Stay up to date with the latest company news

Sign Up